The Market Reports

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Safety Testing Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Drug Testing
1.2.3 Drug Analysis
1.3 Market by Application
1.3.1 Global Drug Safety Testing Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.3.4 Medical Device Manufacturer
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Safety Testing Market Perspective (2018-2029)
2.2 Drug Safety Testing Growth Trends by Region
2.2.1 Global Drug Safety Testing Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Drug Safety Testing Historic Market Size by Region (2018-2023)
2.2.3 Drug Safety Testing Forecasted Market Size by Region (2024-2029)
2.3 Drug Safety Testing Market Dynamics
2.3.1 Drug Safety Testing Industry Trends
2.3.2 Drug Safety Testing Market Drivers
2.3.3 Drug Safety Testing Market Challenges
2.3.4 Drug Safety Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Safety Testing Players by Revenue
3.1.1 Global Top Drug Safety Testing Players by Revenue (2018-2023)
3.1.2 Global Drug Safety Testing Revenue Market Share by Players (2018-2023)
3.2 Global Drug Safety Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Drug Safety Testing Revenue
3.4 Global Drug Safety Testing Market Concentration Ratio
3.4.1 Global Drug Safety Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Safety Testing Revenue in 2022
3.5 Drug Safety Testing Key Players Head office and Area Served
3.6 Key Players Drug Safety Testing Product Solution and Service
3.7 Date of Enter into Drug Safety Testing Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Safety Testing Breakdown Data by Type
4.1 Global Drug Safety Testing Historic Market Size by Type (2018-2023)
4.2 Global Drug Safety Testing Forecasted Market Size by Type (2024-2029)
5 Drug Safety Testing Breakdown Data by Application
5.1 Global Drug Safety Testing Historic Market Size by Application (2018-2023)
5.2 Global Drug Safety Testing Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Drug Safety Testing Market Size (2018-2029)
6.2 North America Drug Safety Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Drug Safety Testing Market Size by Country (2018-2023)
6.4 North America Drug Safety Testing Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Safety Testing Market Size (2018-2029)
7.2 Europe Drug Safety Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Drug Safety Testing Market Size by Country (2018-2023)
7.4 Europe Drug Safety Testing Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Safety Testing Market Size (2018-2029)
8.2 Asia-Pacific Drug Safety Testing Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Drug Safety Testing Market Size by Region (2018-2023)
8.4 Asia-Pacific Drug Safety Testing Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Safety Testing Market Size (2018-2029)
9.2 Latin America Drug Safety Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Drug Safety Testing Market Size by Country (2018-2023)
9.4 Latin America Drug Safety Testing Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Safety Testing Market Size (2018-2029)
10.2 Middle East & Africa Drug Safety Testing Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Drug Safety Testing Market Size by Country (2018-2023)
10.4 Middle East & Africa Drug Safety Testing Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ArisGlobal LLC
11.1.1 ArisGlobal LLC Company Detail
11.1.2 ArisGlobal LLC Business Overview
11.1.3 ArisGlobal LLC Drug Safety Testing Introduction
11.1.4 ArisGlobal LLC Revenue in Drug Safety Testing Business (2018-2023)
11.1.5 ArisGlobal LLC Recent Development
11.2 Eurofins
11.2.1 Eurofins Company Detail
11.2.2 Eurofins Business Overview
11.2.3 Eurofins Drug Safety Testing Introduction
11.2.4 Eurofins Revenue in Drug Safety Testing Business (2018-2023)
11.2.5 Eurofins Recent Development
11.3 Clario
11.3.1 Clario Company Detail
11.3.2 Clario Business Overview
11.3.3 Clario Drug Safety Testing Introduction
11.3.4 Clario Revenue in Drug Safety Testing Business (2018-2023)
11.3.5 Clario Recent Development
11.4 Charles River
11.4.1 Charles River Company Detail
11.4.2 Charles River Business Overview
11.4.3 Charles River Drug Safety Testing Introduction
11.4.4 Charles River Revenue in Drug Safety Testing Business (2018-2023)
11.4.5 Charles River Recent Development
11.5 Pace Analytical Services
11.5.1 Pace Analytical Services Company Detail
11.5.2 Pace Analytical Services Business Overview
11.5.3 Pace Analytical Services Drug Safety Testing Introduction
11.5.4 Pace Analytical Services Revenue in Drug Safety Testing Business (2018-2023)
11.5.5 Pace Analytical Services Recent Development
11.6 LabCorp
11.6.1 LabCorp Company Detail
11.6.2 LabCorp Business Overview
11.6.3 LabCorp Drug Safety Testing Introduction
11.6.4 LabCorp Revenue in Drug Safety Testing Business (2018-2023)
11.6.5 LabCorp Recent Development
11.7 ICON plc.
11.7.1 ICON plc. Company Detail
11.7.2 ICON plc. Business Overview
11.7.3 ICON plc. Drug Safety Testing Introduction
11.7.4 ICON plc. Revenue in Drug Safety Testing Business (2018-2023)
11.7.5 ICON plc. Recent Development
11.8 Boston Analytical
11.8.1 Boston Analytical Company Detail
11.8.2 Boston Analytical Business Overview
11.8.3 Boston Analytical Drug Safety Testing Introduction
11.8.4 Boston Analytical Revenue in Drug Safety Testing Business (2018-2023)
11.8.5 Boston Analytical Recent Development
11.9 Catalent
11.9.1 Catalent Company Detail
11.9.2 Catalent Business Overview
11.9.3 Catalent Drug Safety Testing Introduction
11.9.4 Catalent Revenue in Drug Safety Testing Business (2018-2023)
11.9.5 Catalent Recent Development
11.10 Parexel International Corporation
11.10.1 Parexel International Corporation Company Detail
11.10.2 Parexel International Corporation Business Overview
11.10.3 Parexel International Corporation Drug Safety Testing Introduction
11.10.4 Parexel International Corporation Revenue in Drug Safety Testing Business (2018-2023)
11.10.5 Parexel International Corporation Recent Development
11.11 Altasciences
11.11.1 Altasciences Company Detail
11.11.2 Altasciences Business Overview
11.11.3 Altasciences Drug Safety Testing Introduction
11.11.4 Altasciences Revenue in Drug Safety Testing Business (2018-2023)
11.11.5 Altasciences Recent Development
11.12 Hangzhou Huante Biotechnology Co., Ltd.
11.12.1 Hangzhou Huante Biotechnology Co., Ltd. Company Detail
11.12.2 Hangzhou Huante Biotechnology Co., Ltd. Business Overview
11.12.3 Hangzhou Huante Biotechnology Co., Ltd. Drug Safety Testing Introduction
11.12.4 Hangzhou Huante Biotechnology Co., Ltd. Revenue in Drug Safety Testing Business (2018-2023)
11.12.5 Hangzhou Huante Biotechnology Co., Ltd. Recent Development
11.13 Boende Testing
11.13.1 Boende Testing Company Detail
11.13.2 Boende Testing Business Overview
11.13.3 Boende Testing Drug Safety Testing Introduction
11.13.4 Boende Testing Revenue in Drug Safety Testing Business (2018-2023)
11.13.5 Boende Testing Recent Development
11.14 Microspectroscopy Technology Co., Ltd.
11.14.1 Microspectroscopy Technology Co., Ltd. Company Detail
11.14.2 Microspectroscopy Technology Co., Ltd. Business Overview
11.14.3 Microspectroscopy Technology Co., Ltd. Drug Safety Testing Introduction
11.14.4 Microspectroscopy Technology Co., Ltd. Revenue in Drug Safety Testing Business (2018-2023)
11.14.5 Microspectroscopy Technology Co., Ltd. Recent Development
11.15 Pharmaron
11.15.1 Pharmaron Company Detail
11.15.2 Pharmaron Business Overview
11.15.3 Pharmaron Drug Safety Testing Introduction
11.15.4 Pharmaron Revenue in Drug Safety Testing Business (2018-2023)
11.15.5 Pharmaron Recent Development
11.16 JOINN
11.16.1 JOINN Company Detail
11.16.2 JOINN Business Overview
11.16.3 JOINN Drug Safety Testing Introduction
11.16.4 JOINN Revenue in Drug Safety Testing Business (2018-2023)
11.16.5 JOINN Recent Development
11.17 Shanghai InnoStar Bio-tech Co., Ltd
11.17.1 Shanghai InnoStar Bio-tech Co., Ltd Company Detail
11.17.2 Shanghai InnoStar Bio-tech Co., Ltd Business Overview
11.17.3 Shanghai InnoStar Bio-tech Co., Ltd Drug Safety Testing Introduction
11.17.4 Shanghai InnoStar Bio-tech Co., Ltd Revenue in Drug Safety Testing Business (2018-2023)
11.17.5 Shanghai InnoStar Bio-tech Co., Ltd Recent Development
11.18 WESTCHINA-FRONTIE PHARMA TECH
11.18.1 WESTCHINA-FRONTIE PHARMA TECH Company Detail
11.18.2 WESTCHINA-FRONTIE PHARMA TECH Business Overview
11.18.3 WESTCHINA-FRONTIE PHARMA TECH Drug Safety Testing Introduction
11.18.4 WESTCHINA-FRONTIE PHARMA TECH Revenue in Drug Safety Testing Business (2018-2023)
11.18.5 WESTCHINA-FRONTIE PHARMA TECH Recent Development
11.19 Shanghai Medicilon
11.19.1 Shanghai Medicilon Company Detail
11.19.2 Shanghai Medicilon Business Overview
11.19.3 Shanghai Medicilon Drug Safety Testing Introduction
11.19.4 Shanghai Medicilon Revenue in Drug Safety Testing Business (2018-2023)
11.19.5 Shanghai Medicilon Recent Development
11.20 Hangzhou Rongchuang Biological Co., Ltd.
11.20.1 Hangzhou Rongchuang Biological Co., Ltd. Company Detail
11.20.2 Hangzhou Rongchuang Biological Co., Ltd. Business Overview
11.20.3 Hangzhou Rongchuang Biological Co., Ltd. Drug Safety Testing Introduction
11.20.4 Hangzhou Rongchuang Biological Co., Ltd. Revenue in Drug Safety Testing Business (2018-2023)
11.20.5 Hangzhou Rongchuang Biological Co., Ltd. Recent Development
11.21 WuXi AppTec
11.21.1 WuXi AppTec Company Detail
11.21.2 WuXi AppTec Business Overview
11.21.3 WuXi AppTec Drug Safety Testing Introduction
11.21.4 WuXi AppTec Revenue in Drug Safety Testing Business (2018-2023)
11.21.5 WuXi AppTec Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details